Bowel ulceration following tocilizumab administration in a COVID-19 patient
10.1136/bmjgast-2020-000484
Saved in:
Main Authors: | Bruce-Hickman, D, Sajeed, SM, Pang, YH, Seow, CS, Chen, W, Gulati Kansal, M |
---|---|
Other Authors: | PATHOLOGY |
Format: | Article |
Published: |
BMJ
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/194892 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Response to Letter Regarding “How Should the Rehabilitation Community Prepare for 2019-nCoV?”
by: Hoenig, H, et al.
Published: (2022) -
The many estimates of the COVID-19 case fatality rate
by: Rajgor, DD, et al.
Published: (2021) -
Kawasaki disease in the COVID-19 era: a distinct clinical phenotype?
by: Kam, KQ, et al.
Published: (2021) -
Internal Medicine Residency Training in the COVID-19 Era-Reflections From Singapore
by: Kee, A, et al.
Published: (2022) -
Understanding the Singapore COVID-19 experience: Implications for hospital medicine
by: Vidyarthi, AR, et al.
Published: (2021)